SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
  
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
1. Name and Address of Reporting Person*
BERGERON DANIEL A

(Last) (First) (Middle)
129 PEACEABLE STREET

(Street)
REDDING CT 06896

(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
RBC Bearings INC [ ROLL ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
X Director 10% Owner
X Officer (give title below) Other (specify below)
VP, CFO and COO
3. Date of Earliest Transaction (Month/Day/Year)
07/08/2019
4. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock 07/08/2019 F 1,545(1) D $166.01 82,292(2) D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Option to Purchase Common Stock $51.08 06/14/2014 06/14/2020 Common Stock 20,000 20,000 D
Option to Purchase Common Stock $64.15 07/01/2015 07/01/2021 Common Stock 20,000 20,000 D
Option to Purchase Common Stock $72.83 07/01/2016(3) 07/01/2022 Common Stock 25,000 25,000 D
Option to Purchase Common Stock $72.94 07/08/2017(4) 07/08/2023 Common Stock 40,000 40,000 D
Option to Purchase Common Stock $99.64 06/27/2018(5) 06/27/2024 Common Stock 30,000 30,000 D
Option to Purchase Common Stock $132.12 06/07/2019(6) 06/07/2025 Common Stock 35,000 35,000 D
Option to Purchase Common Stock $143.92 06/03/2020(7) 06/03/2026 Common Stock 35,000 35,000 D
Explanation of Responses:
1. Represents shares withheld by the Company to pay tax liability related to the vesting of restricted stock
2. Includes 45,000 shares of restricted stock, which vest according to the following schedule; 3,333 shares vest on 6/27/2020; 16,667 shares 1/2 of which vest on 6/7/2020 and 1/2 vest on 6/7/2021; and 25,000 shares 1/3 of which vest on 6/3/2020, 1/3 vest on 6/3/2021 and 1/3 vest on 6/3/2022.
3. All these options to purchase Common Stock are exercisable except for 5,000 options that vest on 7/1/2020.
4. All these options to purchase Common Stock are exercisable except for 16,000 options that are subject to the following vesting schedule - 1/2 vest on 7/8/2020 and 1/2 vest on 7/8/2021.
5. All these options to purchase Common Stock are exercisable except for 18,000 options that are subject to the following vesting schedule - 1/3 vest on 6/27/2020, 1/3 vest on 6/27/2021 and 1/3 vest on 6/27/2022.
6. All these options to purchase Common Stock are exercisable except for 28,000 options that are subject to the following vesting schedule - 1/4 vest on 6/7/2020, 1/4 vest on 6/7/2021, 1/4 vest on 6/7/2022 and 1/4 vest on 6/7/2023.
7. Options to purchase shares of Common Stock are subject to the following vesting schedule - 1/5 vest on 6/3/2020, 1/5 vest on 6/3/2021, 1/5 vest on 6/3/2022, 1/5 vest on 6/3/2023 and 1/5 vest on 6/3/2024.
Remarks:
/s/Joseph Salamunovich/attorney in fact 07/09/2019
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.